Who owns Newamsterdam Pharma Company (NAMS)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Newamsterdam Pharma Company (NAMS) in their latest 13F filing, with $688.7M between them. Peter Kolchinsky gives it the most weight: 2.81% of the reported portfolio. In their latest reported quarter, Lee Ainslie added.
Ron Baron sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- Peter Kolchinsky, $323.7M
- Largest weight
- Peter Kolchinsky, 2.81%of their portfolio
- Combined value
- $688.7M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Peter KolchinskyRA Capital Management | 2.81% | $323.7M | 9.55M | No change | 0 | Q2 2026 |
| 2 | Stanley DruckenmillerDuquesne Family Office | 2.39% | $104M | 3.07M | No change | 0 | Q2 2026 |
| 3 | Lee AinslieMaverick Capital | 1.00% | $110.7M | 3.27M | ▲ Added 49% | +1.08M | Q2 2026 |
| 4 | Andreas HalvorsenViking Global Investors | 0.41% | $142.5M | 4.2M | No change | 0 | Q2 2026 |
| 5 | David GreenspanSlate Path Capital | 0.12% | $7.8M | 319K | No change | 0 | Q3 2026 |
Sold out last quarter
- Ron Baronwas $305K · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 319K | $7.8M | 0 | 1 |
| Q2 2026 | 157 | 5 | 20.41M | $691.7M | 1 | 0 |
| Q1 2026 | 157 | 5 | 19.33M | $618.7M | 1 | 1 |
| Q4 2025 | 157 | 5 | 19.04M | $667.8M | 2 | 2 |
| Q3 2025 | 157 | 5 | 20.36M | $579.1M | 1 | 2 |
| Q2 2025 | 157 | 5 | 19.8M | $358.6M | 2 | 0 |
| Q1 2025 | 156 | 5 | 18.79M | $384.6M | 3 | 0 |
| Q4 2024 | 156 | 5 | 16.78M | $431.2M | 3 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| David Greenspan | 319K | 319K | 319K | 319K | 319K | 319K | 319K | 319K |
| Peter Kolchinsky | · | 9.55M | 9.55M | 9.55M | 10.14M | 10.14M | 10.14M | 8.85M |
| Andreas Halvorsen | · | 4.2M | 4.2M | 4.2M | 6.48M | 6.98M | 6.98M | 6.98M |
| Lee Ainslie | · | 3.27M | 2.19M | 1.89M | 1.5M | 1.53M | 549.47K | 350.01K |
| Stanley Druckenmiller | · | 3.07M | 3.07M | 3.07M | 1.92M | 832.18K | 800.36K | 287.54K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own NAMS?
In their latest 13F filings: Peter Kolchinsky (2.81% of the portfolio, $323.7M), Stanley Druckenmiller (2.39% of the portfolio, $104M), Lee Ainslie (1.00% of the portfolio, $110.7M), Andreas Halvorsen (0.41% of the portfolio, $142.5M), David Greenspan (0.12% of the portfolio, $7.8M).
Who bought NAMS last quarter?
Lee Ainslie (added 49%). “Last quarter” is each investor's latest reported quarter.
Who sold NAMS last quarter?
Sold out entirely: Ron Baron (was $305K).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Newamsterdam Pharma Company (NAMS)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/NAMS/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to NAMS by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.